BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16799769)

  • 1. Phytanic acid: production from phytol, its breakdown and role in human disease.
    van den Brink DM; Wanders RJ
    Cell Mol Life Sci; 2006 Aug; 63(15):1752-65. PubMed ID: 16799769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid.
    van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Jansen GA; Wanders RJ
    Mol Genet Metab; 2004 May; 82(1):33-7. PubMed ID: 15110319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.
    Wierzbicki AS
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):881-6. PubMed ID: 17956237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorders related to the metabolism of phytanic acid.
    Stokke O; Skjeldal OH; Høie K
    Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
    Wanders RJ; Komen JC
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of phytanic acid omega-hydroxylation in human liver microsomes.
    Komen JC; Duran M; Wanders RJ
    Mol Genet Metab; 2005 Jul; 85(3):190-5. PubMed ID: 15979030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
    Pahan K; Khan M; Singh I
    J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
    Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
    Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
    Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
    J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytanic acid metabolism in health and disease.
    Wanders RJ; Komen J; Ferdinandusse S
    Biochim Biophys Acta; 2011 Sep; 1811(9):498-507. PubMed ID: 21683154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of oxidation from phytol to phytanic acid in man.
    Wierzbicki AS
    Mol Genet Metab; 2004 Dec; 83(4):347. PubMed ID: 15589124
    [No Abstract]   [Full Text] [Related]  

  • 12. Refsum disease, peroxisomes and phytanic acid oxidation: a review.
    Wanders RJ; Jansen GA; Skjeldal OH
    J Neuropathol Exp Neurol; 2001 Nov; 60(11):1021-31. PubMed ID: 11706932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata.
    Brites P; Motley AM; Gressens P; Mooyer PA; Ploegaert I; Everts V; Evrard P; Carmeliet P; Dewerchin M; Schoonjans L; Duran M; Waterham HR; Wanders RJ; Baes M
    Hum Mol Genet; 2003 Sep; 12(18):2255-67. PubMed ID: 12915479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
    Xu F; Ng VY; Kroetz DL; de Montellano PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):835-9. PubMed ID: 16707724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal trans-2-enoyl-CoA reductase is involved in phytol degradation.
    Gloerich J; Ruiter JP; van den Brink DM; Ofman R; Ferdinandusse S; Wanders RJ
    FEBS Lett; 2006 Apr; 580(8):2092-6. PubMed ID: 16546181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
    Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
    Biochim Biophys Acta; 1997 Oct; 1361(3):281-6. PubMed ID: 9375802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the final step in the conversion of phytol into phytanic acid.
    van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Wanders RJ
    J Biol Chem; 2005 Jul; 280(29):26838-44. PubMed ID: 15866875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human metabolism of phytanic acid and pristanic acid.
    Verhoeven NM; Jakobs C
    Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of SCP-x gene ablation on branched-chain fatty acid metabolism.
    Atshaves BP; McIntosh AL; Landrock D; Payne HR; Mackie JT; Maeda N; Ball J; Schroeder F; Kier AB
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G939-51. PubMed ID: 17068117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
    Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
    J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.